Hospital Mater Dei (BSP:MATD3) Net Margin %: 5.66% (As of Mar. 2026) — 29% Below Median


BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
85 GF Score
Price R$4.86
GF Value R$5.85
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Net Margin %?

Hospital Mater Dei BSP:MATD3 +3.18% 85 Net Margin % is 5.66% as of Mar. 2026, which is 29% below its 10-year median of 8.00. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 62.87% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Hospital Mater Dei's Net Income for the three months ended in Mar. 2026 was R$33 Mil. Hospital Mater Dei's Revenue for the three months ended in Mar. 2026 was R$575 Mil. Therefore, Hospital Mater Dei's net margin for the quarter that ended in Mar. 2026 was 5.66%.

The historical rank and industry rank for Hospital Mater Dei's Net Margin % or its related term are showing as below:

BSP:MATD3' s Net Margin % Range Over the Past 10 Years
Min: -15.2   Med: 8   Max: 19.86
Current: 5.47


BSP:MATD3's Net Margin % is ranked better than
62.87% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 2.885 vs BSP:MATD3: 5.47

Hospital Mater Dei  (BSP:MATD3) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Hospital Mater Dei Net Margin % Related Terms


Hospital Mater Dei Net Margin % Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Net Margin % Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only 14.15 5.87 5.47 -15.20 5.08

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.99 4.81 4.73 6.67 5.66

BSP:MATD3 vs HCA, THC, DVA: Net Margin % Comparison

For the Medical Care Facilities subindustry, Hospital Mater Dei's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hospital Mater Dei Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Net Margin % distribution charts can be found below:

* The bar in red indicates where Hospital Mater Dei's Net Margin % falls into.


BSP:MATD3
85GF Score
Hospital Mater Dei SA BSP:MATD3
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Hospital Mater Dei's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=110.511/2175.285
=5.08 %

Hospital Mater Dei's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=32.566/574.958
=5.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 5.66% mean?
Hospital Mater Dei (BSP:MATD3) has a Net Margin % of 5.66% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Hospital Mater Dei and its competitors. This is 29% below median its historical median of 8.00. According to the industry distribution chart, Hospital Mater Dei ranks #248 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 37.1%.
Is Hospital Mater Dei's Net Margin % too high?
Hospital Mater Dei's current Net Margin % of 5.66% is 29% below median its 10-year median of 8.00. The Healthcare Providers & Services industry median Net Margin % is 2.89. Hospital Mater Dei's value of 5.66% is 96.2% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #248 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #248 out of 668 companies for Net Margin %. This puts Hospital Mater Dei in the upper half of its industry. The industry median Net Margin % is 2.89. Hospital Mater Dei's value of 5.66% is 96.2% above this benchmark. While the company's 10-year median is 8.00 vs. the industry median of 2.89, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Net Margin % of 5.66% is 96.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Net Margin % is 5.66%, which is 29% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.85, compared to a current price of R$4.86 — trading 16.9% below its estimated fair value. The current Net Margin % is 5.66%, which is 29% below median its 10-year median of 8.00 and 96.2% above the Healthcare Providers & Services industry median of 2.89. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Net Margin % is 5.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.86 is trading 16.9% below its estimated GF Value™ of R$5.85. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Net Margin %: 5.66% (29% below median its 10-year median of 8.00)
  • GF Value™: R$5.85 vs. price of R$4.86 (16.9% below fair value)
  • GF Score™: 85/100 with 3 warning signs
  • Industry Position: 96.2% above the Healthcare Providers & Services median (#248 of 668)

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score

Get the complete analysis for BSP:MATD3

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.86
Price
R$5.85
GF Value